Table 2 Clinical signs and symptoms at the time of treatment intensification during 0–4 weeks and during 4–52 weeks
Clinical signs and symptoms | During 0–4 weeks n=29 | During 4–52 weeks n=18 |
|---|---|---|
Fever (>39.0°C), % | 55.2 | 52.9 |
Rashes, % | 37.9 | 35.2 |
Lymphadenopathy, % | 10.3 | 11.8 |
Hepatosplenomegaly, % | 6.9 | 11.8 |
Elevated liver enzymes, % | 58.6 | 29.4 |
Pericarditis, % | 10.3 | 0 |
Pleuritis, % | 17.2 | 0 |
Interstitial pneumonia, % | 6.9 | 0 |
Arthritis, % | 37.9 | 33.3 |
Hemophagocytic syndrome, % | 13.8 | 0 |
DIC, % | 13.8 | 0 |
CRP elevation without clinical signs and symptoms, % | 0 | 11.1 |